-+ 0.00%
-+ 0.00%
-+ 0.00%

Clear Street Maintains Buy on Protagonist Therapeutics, Raises Price Target to $116

Benzinga·04/07/2026 10:10:13
Listen to the news
Clear Street analyst Kaveri Pohlman maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and raises the price target from $104 to $116.